19-11128126-C-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BA1BP4
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.2389+41C>A variant is classified as Benign for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes BA1 and BP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 24 March 2025. The supporting evidence is as follows: BA1: FAF = 0.01376 (1.376%) in African/African American exomes (gnomAD v4.1.0).BP4: No REVEL, splicing evaluation required. Functional data on splicing not available. A) not on limits. B) Does not create a GT. C) No nearby GT. Variant is not predicted to alter splicing. LINK:https://erepo.genome.network/evrepo/ui/classification/CA040197/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLR | NM_000527.5 | c.2389+41C>A | intron_variant | Intron 16 of 17 | ENST00000558518.6 | NP_000518.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00981 AC: 1493AN: 152132Hom.: 11 Cov.: 31
GnomAD3 exomes AF: 0.00814 AC: 2040AN: 250664Hom.: 14 AF XY: 0.00820 AC XY: 1112AN XY: 135614
GnomAD4 exome AF: 0.00867 AC: 12342AN: 1423606Hom.: 60 Cov.: 27 AF XY: 0.00871 AC XY: 6188AN XY: 710356
GnomAD4 genome AF: 0.00984 AC: 1498AN: 152250Hom.: 11 Cov.: 31 AF XY: 0.00998 AC XY: 743AN XY: 74446
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Uncertain:1Benign:1
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at